Institute of Clinical Physiology, CNR, Massa, Italy.
Ospedale del Cuore, Fondazione Toscana "G. Monasterio", Massa, Italy.
Per Med. 2024;21(3):139-144. doi: 10.2217/pme-2023-0135. Epub 2024 Apr 18.
We report the clinical presentation and genetic screening of a 31-year-old man with dilatation of the aortic root and ascending aorta and a positive family history for aortic dissection and sudden death. A novel heterozygous variant in a splice acceptor site (c.1600-1G>T) of TGFβR2 gene was identified by using a targeted multi-gene panel analysis. Bioinformatics tools predicted that the c.1600-1G>T variant is pathogenic by altering acceptor splice site at - 1 position affecting pre-mRNA splicing. These data confirm that the diverging splicing in the TGF-β pathway genes may be an important process in aneurismal disease and emphasize the utility of genetic sequencing in the identification of high-risk patients for a more patient's management able to improve outcomes and minimize costs for the care of patients with heritable thoracic aortic aneurysm and dissection.
我们报告了一位 31 岁男性的临床表型和基因筛查结果,该男性患有主动脉根部和升主动脉扩张,并有主动脉夹层和猝死的阳性家族史。通过使用靶向多基因panel 分析,发现 TGFβR2 基因剪接受体位点(c.1600-1G>T)的一个新的杂合变异。生物信息学工具预测 c.1600-1G>T 变异通过改变-1 位的接受剪接位点影响前体 mRNA 剪接,从而具有致病性。这些数据证实 TGF-β 通路基因的可变剪接可能是动脉瘤疾病的一个重要过程,并强调了基因测序在鉴定遗传性胸主动脉瘤和夹层的高危患者中的作用,以便更好地管理患者,改善预后并降低患者的治疗费用。